KB Home
KBH
Lennar Corp
LEN
Salesforce
CRM
Toll Brothers
TOL
Apple
AAPL
US Stock MarketDetailed Quotes
RXRX Recursion Pharmaceuticals
- 7.030
- -0.300-4.09%
Close Jan 27 16:00 ET
- 7.170
- +0.140+1.99%
Pre 05:27 ET
2.75BMarket Cap-4.56P/E (TTM)
7.330High6.720Low21.35MVolume6.980Open7.330Pre Close148.92MTurnover6.00%Turnover RatioLossP/E (Static)390.72MShares15.74052wk High5.23P/B2.50BFloat Cap5.60052wk Low--Dividend TTM356.02MShs Float42.810Historical High--Div YieldTTM8.32%Amplitude4.540Historical Low6.976Avg Price1Lot Size
Recursion Pharmaceuticals News
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 424B7: Prospectus
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
